MedMira strengthen its Board with New Appointment

Halifax, Nova Scotia, 17 December 2021 – Today, MedMira Inc. (MedMira) (TSXV: MIR) announced today the appointment of Mr. Thomas Bergmann to the board effective immediately. Mr. Bergmann is the former CEO and Member of the Board of the US based pharmaceutical company Macromed Inc. which was sold to a publicly traded pharmaceutical company in […]